Snap Bio, Inc.

Snap Bio is a preclinical oncology company focused on delivering first-in-class treatments through a pioneering approach and platform. Our mission is to help patients suffering from challenging cancers where improved therapeutics are needed most. Snap Bio's unique approach starts with extremely potent inhibitors that have been evolved in Nature over millions of years. Rather than relying solely on conventional medicinal chemistry to modify these privileged scaffolds, Snap Bio employs its breakthrough synthetic biology platform to generate scaffold diversity and rapidly optimize selectivity and other properties important for clinical success. This approach has been validated through our lead program involving highly potent and selective inhibitors that disrupt multiple genetically-defined cancer growth and survival pathways. Snap Bio is advancing its promising liver cancer program, with a long-term goal of expanding to other cancer types in which its lead molecules already have shown strong efficacy.

Website

http://www.snap-bio.com

External link for Snap Bio, Inc.

Industry

Biotechnology Research

Company size

2-10 employees

Headquarters

San Diego, California

Type

Privately Held

Founded

2017